2026-10-30 12:47:26 UTC#545654newconfirmednews
West Pharmaceutical Services (WST) stock news
West Pharmaceutical Services (WST) stock news. Deduplicated factual headlines, scored for importance, with entity sentiment and the sectors, countries, and asset classes affected. Updates open into the storyline.
See the full wire20 wire items
2026-10-29 14:23:07 UTC#538185duplicateconfirmednews
West Pharmaceutical Services Q3 Results Driven by HVP Demand, Full-Year Guidance Raised
2026-10-29 10:09:22 UTC#536024duplicateconfirmednews
West Pharmaceutical Services beats Q3 2026 estimates and raises full-year outlook
2026-10-29 10:01:02 UTC#535911newconfirmeddata release
West Pharmaceutical Q3 Adj. EPS $2.66 vs $2.19 est, Revenue $874.5M vs $825.7M est; Raises FY Outlook
2026-10-29 10:00:00 UTC#536164duplicateconfirmednews
West Pharmaceutical Services (WST) Q3 Results Beat Expectations, Full-Year 2026 Guidance Raised
2026-10-29 10:00:00 UTC#536162updateconfirmednews
West Pharmaceutical Services (WST) issues FY 2026 sales guidance of $3.41B-$3.42B
2026-10-29 10:00:00 UTC#536161updateconfirmednews
West Pharmaceutical Services (WST) lowers FY 2026 adjusted EPS guidance to $9.31-$9.41
2026-10-29 10:00:00 UTC#536157updateconfirmednews
West Pharmaceutical Services (WST) issues FY 2026 adjusted EPS guidance of $9.38 to $9.48
2026-10-29 10:00:00 UTC#536156updateconfirmeddata release
West Pharmaceutical Services (WST) reports Q3 2026 sales of $874.5 million
2026-10-29 10:00:00 UTC#536152duplicateconfirmednews
West Pharmaceutical Services reports Q3 2026 net income of $214 million
2026-10-29 10:00:00 UTC#536151correctionconfirmeddata release
West Pharmaceutical Services (WST) Q3 EPS corrected to $3.02 from previously reported $2.66
2026-10-29 10:00:00 UTC#536148newconfirmeddata release
West Pharmaceutical Services (WST) reports Q3 2026 adjusted EPS of $2.66
2026-10-28 16:59:33 UTC#530724newforecastanalysis
West Pharmaceutical Services Q3 2026 Earnings Preview
2026-10-26 21:23:00 UTC#517512newconfirmednews
West Pharmaceutical Services secures $950M five-year credit facility, refinances existing debt
tradingviewimportance 0.40trust 0.80West Pharmaceutical Services, Inc. +0.10Bank of America Corporation 0
2026-10-19 22:25:00 UTC#483533duplicateconfirmednews
West Pharmaceutical Services increases quarterly dividend by 18% to $0.26 per share
2026-10-19 22:06:00 UTC#483475newconfirmednews
West Pharmaceutical Services (WST) raises quarterly dividend to $0.26 from $0.22
2026-10-13 16:50:00 UTC#453874newconfirmednews
TD Cowen raises West Pharmaceutical Services price target to $420 from $410, maintains Buy rating
2026-10-08 10:00:00 UTC#431088newconfirmedpress release
West Pharmaceutical Services (WST) to report Q3 2026 financial results on October 29, 2026
2026-09-14 13:47:12 UTC#307797newconfirmednews
West Pharmaceutical Services (WST) raises full-year guidance after 13% Q2 revenue growth
2026-09-10 21:40:01 UTC#295404newconfirmednews
West Pharmaceutical Services CHRO Annette F. Favorite sells $2.77M in company stock
tradingviewimportance 0.30trust 0.90West Pharmaceutical Services, Inc. -0.10Annette F. Favorite -0.10